• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Opthalmology Times, Digital Edition, May 15th, 2010

Article

Related Videos
Related Content
EyeCon 2023: Reducing patients' retinal burden of care

EyeCon 2023: Reducing patients' retinal burden of care

Article
Week in Review - November 26, 2023

Week in Review - November 26, 2023

Podcast
Systematic review suggests vitamin D deficiency doubles risk of noninfectious uveitis

Systematic review suggests vitamin D deficiency doubles risk of noninfectious uveitis

Article
Week in Review - November 12, 2023

Week in Review - November 12, 2023

Podcast
Kubota Vision announces multiple partnerships around its eyeMO OCT device

Kubota Vision announces multiple partnerships around its eyeMO OCT device

Article
Oculis announces first patient first visit in Phase 2b RELIEF Trial of Topical Anti-TNFα licaminlimab in dry eye disease

Oculis announces first patient first visit in Phase 2b RELIEF Trial of Topical Anti-TNFα licaminlimab in dry eye disease

Article
© 2023 MJH Life Sciences

All rights reserved.